Immatics Final logo (R)_white_background.png
Immatics Announces Second Quarter 2021 Financial Results and Provides Business Update
10 août 2021 07h00 HE | https://immatics.com/
ACTengine® patient recruitment remains on track; as of end of July, a total of 27 patients have been treated with IMA201, IMA202 or IMA203 across different cancer indicationsTCR Bispecifics pipeline...
grapefruit LOGO.png
Grapefruit USA Reports Cannabis Bumper Crop, Lower Demand due to Pandemic and Economic Uncertainty Contributed to Small Year-over-Year Revenue Decrease
25 mai 2021 15h24 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc., (“GPFT,” “Grapefruit” or the “Company”) (OTCQB: GPFT) a California based...
Immatics Final logo (R)_white_background.png
Immatics veröffentlicht Ergebnisse des ersten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
18 mai 2021 07h00 HE | Immatics N.V.
Daten-Update zu den laufenden klinischen Studien der ACTengine® IMA200 Serie zeigte erste Anti-Tumorwirkung in stark vorbehandelten Patienten mit soliden Tumoren in der frühen Phase der...
Immatics Final logo (R)_white_background.png
Immatics Announces First Quarter 2021 Financial Results and Business Update
18 mai 2021 07h00 HE | https://immatics.com/
Data update for ongoing ACTengine® IMA200 clinical trial series demonstrated first anti-tumor activity in heavily pre-treated solid cancer patients during early phases of dose escalationNext...
Immatics Final logo (R)_white_background.png
Immatics veröffentlicht Ergebnisse des Geschäftsjahres 2020 sowie ein Update zur Geschäftsentwicklung
30 mars 2021 07h00 HE | Immatics N.V.
Erste Anti-Tumorwirkung in den ACTengine® Phase 1a-Studien gezeigtPatientenrekrutierung für die klinischen ACTengine® Studien in Deutschland und USA weiter ausgebautZum 31. Dezember 2020 verfügte...
Immatics Final logo (R)_white_background.png
Immatics Announces Full Year 2020 Financial Results and Corporate Update
30 mars 2021 07h00 HE | https://immatics.com/
Phase 1a data update from clinical ACTengine® programs demonstrated first anti-tumor activity at early phases of dose escalation in heavily pre-treated solid cancer patients Enrollment across...
PCS logo experts.png
PCS Edventures! Reports Unaudited Results for the Third Quarter of Fiscal Year 2021
15 févr. 2021 11h49 HE | PCS Edventures!, Inc.
BOISE, Idaho, Feb. 15, 2021 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone...
Oceana_English_SideTagline_2Blue_CMYK.jpg
Oceana: Amazon (AMZN) reports 38% increase in sales for 2020, but does not address corresponding increase in the company’s plastic use as Bezos plans to step down
03 févr. 2021 17h30 HE | Oceana, Inc.
Oceana calls on company and CEO Jeff Bezos to lead e-commerce industry in showing how to reduce plastics in wake of record-breaking earnings report WASHINGTON, Feb. 03, 2021 (GLOBE NEWSWIRE) --...
GrayscaleLogo.jpg
Investors Direct More Than $3 Billion to Grayscale Investments® in Q4 2020
14 janv. 2021 09h15 HE | Grayscale Investments
New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Grayscale Investments®, the world’s largest digital currency asset manager, today released its 4Q20 Grayscale Digital Asset Report, a comprehensive look...
Immatics Final logo (R)_white_background.png
Immatics Announces Third Quarter 2020 Financial Results and Business Update
02 déc. 2020 07h00 HE | https://immatics.com/
ACTengine® IMA200 clinical trial series continues scaling globally; initial analysis for patients in ACTengine® dose escalation is on track for Q1 2021 Expansion of UTHealth partnership secures...